Lumos Pharma LUMO reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Lumos Pharma beat estimated earnings by 5.05%, reporting an EPS of $-0.94 versus an estimate of $-0.99.
Revenue was up $393 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 4.22% drop in the share price the next day.
To track all earnings releases for Lumos Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.